TAB, My perspective, as an angel investor in non-public startup companies, is that the CEO should always have more than enough money in the bank for "just in case." You never know when something might happen and - if you were going to the bank - you often need to show you don't need the money before borrowing it.
While we have most of the Aspire money available and the rest of the "shelf" registered for possible sale at the SEC, the degree of potential dilution will vary dramatically depending on the share price. However, cash is cash.
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links